8.3% constant currency revenue growth in h1 as customers gradually return to labs

Cambridge, united kingdom, march 08, 2021 (globe newswire) -- abcam plc (nasdaq: abcm; aim: abc) (“abcam”, the “group” or the “company”), a global leader in the supply of life science research tools, today announces its interim results for the six month period ended 31 december 2020 (“h1 2021”).
ABCM Ratings Summary
ABCM Quant Ranking